First, a bit of context: when your cells make proteins, the ribosome read a sequence from mRNA in the form of three-letter codes (called codons). There are 64 possible codons which specify 20 amino acids or a STOP sequence to indicate the end of the protein.
Because the codons are read 3 letters at a time, it is possible to start reading them in the wrong spot (either 1 or 2 letters over) and end up with a protein that is completely different from the one you intended because this will change the amino acid downstream because...
the codons will now be completely different. If this occurs it is known as a frameshift (note: if a frameshift occurs 3 bases over, then this doesn't happen because the reading frame won't be affected, but you may duplicate or lose 1 amino acid).
In general, frameshifts are not what you want as an outcome of protein production- but not always. Frameshifts are uncommon but naturally occurring events in, for example, viral infections. These give rise to protein products that can also be targeted by the immune system.
For example, it was recently shown that influenza can produce a unique protein product through a frameshift that is very strongly recognized by killer T cells:
This resulting frameshifted product might have an important role in protection from flu.nature.com/articles/s4159…
Coronaviruses have evolved to require frameshifting as part of their replication cycle to make their proteins:
Anyway, let’s get back to this paper. mRNA vaccines are made with replacement of all of the U’s in the sequence of interest with m1ψ.jbc.org/article/S0021-…
This modification naturally occurs in our own ribosomal RNA. RNA has to be modified to prevent triggering of an antiviral immune response that would suppress production of the encoded protein (which would then prevent an effective antibody response):
Prior work has shown that this results in faithful production of the protein product of interest (spike):
This is a really important point not to lose sight of: the mRNA vaccines are excellent at making the thing we want them to make.ncbi.nlm.nih.gov/pmc/articles/P…
This work argues however that this modification promotes frameshifting. Let’s take a look. First, the authors used a sample mRNA sequence that was designed to produce the end of the enzyme luciferase, which is what enables fireflies to glow.
If the Fluc+1FS RNA were made without frameshift mutations, then there wouldn’t be detectable luciferase activity from the frameshifted product. Here we can see that the m1ψ produced luciferase has the frameshifted product as evident by activity of the luciferase.
On the western blot examining the protein product resulting from different RNA modifications, while there are 2 additional bands for the m1ψ mRNA, it is noteworthy that there is faithful production of the in-frame product as well.
This broadly agrees with work from 2015 that showed that there is markedly enhanced protein production from m1ψ RNA.
This is, fundamentally, the point of using the modification: you want faithful production of your protein inside actual cells.sciencedirect.com/science/articl…
The authors however took it a step further, wondering whether the frameshifting was actually happening in real life. They vaccinated mice with the Pfizer or Oxford/AZ vaccine and looked for evidence of T cell responses against out-of-frame peptides, and…
the mice that received the Pfizer vaccine did show responses against the out-of-frame peptides (2b). But: they also had greater T cell responses to the in-frame peptides (2c) than those that received Oxford/AZ vaccine.
When they looked in humans, they found that the recipients of the Pfizer vaccine also had responses against out-of-frame peptides, but this varied a lot across individuals, suggesting that the extent of frameshifting may also vary a lot between individuals. Note: 2e is mouse data
Anyway, from here, the authors go on to identify “slippery” sites in mRNA that are prone to frameshifting, and they also show that the antibiotic paromomycin (which interferes with decoding of codons by the ribosome) promotes the fidelity of translation with the modified RNA.
The authors show that modification of these sequences to get rid of slippery sites seems to reduce frameshifting events. So, what’s the significance of these results?
In a practical sense as far as it applies to vaccination, IMO not much.
The sequences of Pfizer and Moderna differ significantly at the nucleotide level, but the nature of the responses and their safety profile is broadly similar, arguing against frameshift products in either case having a meaningful effect.
I do think that the major use of these findings is that they highlight the importance of understanding how immune responses against frameshifted peptides affect protection in the case of infection.
The major reason this would be relevant is because it adds a second dimension to codon optimization (because codons are redundant for any given amino acid, you can choose the “best” one for your particular application) in that...
one might want to optimize in such a way that it preserves major frameshifted peptides that may be important for immune responses.
Still, frameshifting within spike protein is not known to date to result in peptides of special importance to the immune response, so...
it’s not likely that it matters much here either way. The authors are (correctly) explicit here that there is no evidence of this contributing to any kind of safety issues with the mRNA vaccines.
Some clueless people claim that this somehow means there's a heightened...
risk of autoimmune disease because of these frameshifted products. For this to be true, there would need to be meaningful production of products that closely resemble our own proteins- something there. is no evidence for.
We in fact see that in stark contrast to COVID-19, there is no autoimmune signature for mRNA vaccines:
So, basically: a useful study but not good cause to worry about mRNA vaccines.nature.com/articles/s4146…
I realized I should perhaps include another point of clarification to help people understand the significance of this issue.
Within cells, any given mRNA is translated by many ribosomes (not just one). mRNA can form assembles of ribosomes called polysomes or polyribosomes:
m1ψ mRNA is particularly good at forming polysomes:
This helps to explain why the yield of proteins from mRNA bearing this modification is so much higher. The significance of this is simply that your cells have a ton of opportunities to make...ncbi.nlm.nih.gov/pmc/articles/P…
the correct protein from any given mRNA. If one ribosome frameshifts, it does not mean *every* ribosome will frameshift. Remember: the frameshifted product was a minor fraction of the overall proteins.
People should also take note that questions about the safety of mRNA vaccines have been repeatedly asked and answered. Data on billions of doses across the last few years affirms their excellent safety profile (reactogenicity notwithstanding). This requires no knowledge...
of cellular and molecular mechanisms. We eradicated smallpox with a vaccine that essentially pre-dates any modern understanding of the immune system. Despite the sexiness of the mechanisms, pharmacoepidemiology is and should always be king of safety evaluations.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I've been yelling for a while about how imprinting is not the problem with our immune responses to Omicron- its intrinsic immunogenicity. This freshly published study provides pretty definitive proof of that 🧵 nature.com/articles/s4159…
The setup here is a bit complex. Using a cohort of individuals from July to December 2021, this group was able to find an unvaccinated and uninfected group of individuals, which allows us to explicitly examine the effects of imprinting because we have people without exposure.
This has previously been done with mice, but not humans. The team looked at antibody responses to the ∆ variant between vaccinated, ∆ infected, and hybrid immune (∆ infection) groups. The gist is: vaccinees draw their response against ∆ mainly from the ancestral variant.
I haven't had the time to go through all of it, but I did catch part of the HELP committee meeting where Kennedy alleges that varicella vaccination leads to shingles outbreaks in older adults. This is not true, but it's worth discussing where this idea comes from 🧵
Chickenpox is caused by the varicella zoster virus (VZV), which is a herpesvirus. This means that it can undergo a process called latency, wherein it remains dormant inside cells and then reactivate. When it reactivates, it can cause herpes zoster- shingles.
This condition has a distinctive rash pattern and causes severe pain, and can even result in a chronic pain syndrome due to scarring of the nerves (postherpetic neuralgia). Depending on where the virus reactivates it can also threaten vision (herpes zoster ophthalmicus)...
Let's go through all the ways this comment is inherently deceitful.
If you go through the entire recommended childhood vaccination schedule, children receive about 4.4 milligrams of aluminum salts in the first 6 months of life.
First, we need to consider the form of aluminum. Vaccines use salts of aluminum as adjuvants- things that potentiate the immune response. Without adjuvants, many vaccines will simply fail to give any meaningful immune response and therefore protection...
and adjuvants allow for dose-sparing of the antigen (the component of the vaccine that the immune system is responding to). Aluminum salts have been used in human vaccines as adjuvants since 1926- literally almost 100 years of data on them.
The idea is simple enough: 155 adults aged 50-70 who received 2 priming doses of Oxford/AZ's COVID-19 vaccine (adenovirus vector) and a licensed booster 3 months before enrollment were randomized to receive a dose of Pfizer, Moderna, or Novavax's vaccines.
People seem to be taking away from this study that Novavax's vaccine somehow gave an immune response that was better than either mRNA vaccine, which is... an odd take. The paper emphasizes that the antibody titer with Novavax was more sustained. This is true, however...
New paper in Cell describes an antibody from Vir that seems to have potent activity against a number of coronaviruses, some of which do not even use ACE2:
First though I want to spend a minute talking about where this antibody came from, because this aspect of things tends to be underappreciated. Before there was Vir-7229, there was S2V29, a candidate antibody that covered all SARS-like coronaviruses:
S2V29 came from a participant who had been vaccinated against and infected with SARS-CoV-2. From there, S2V29 underwent affinity maturation using SARS-CoV-1, SARS-CoV-2, and BQ.1.1 variant RBDs via yeast display. These were then screened and revealed an antibody that had...
3/10
It was preprinted a while ago but since that time I have had an opportunity to talk to some plasma cells researchers and it is apparent that there is a lot of important nuance being missed 🧵nature.com/articles/s4159…
Background: antibodies against the spike protein are protective against infection by SARS-CoV-2. Antibodies are made by antibody-secreting cells (ASCs) which come from B cells and vary widely in their lifespan. The goal of vaccination is generally to elicit durable antibodies.
Long-lived plasma cells (LLPCs) are ASCs that can live for many years (potentially your lifetime). They are canonically found within the bone marrow, but mucosal LLPCs have also been described. The problem: there is no simple way to define look at a cell and say it's an LLPC.